Early Riser (novel)

Early Riser (2018) is a standalone alternate history satire novel of novelist Jasper Fforde.[1][2]

Early Riser
Early Riser (UK 2018 Edition)

AuthorJasper Fforde
Cover artistRobert Frank Hunter
CountryUnited Kingdom
LanguageEnglish
Genrealternate history, fantasy, science fiction, satire
PublisherHodder & Stoughton (UK)
Viking Press (US)
PublishedAugust 2nd, 2018 (UK)
February 12th, 2019 (US)
Media typePrint (hardcover)

Plot

The story takes place in an alternate version of the United Kingdom, where the Ice Age still continues and the human population mainly hibernates in winter. Returning early from hibernation may cause Dead in Sleep from neural collapse, but death during hibernation may also arise from a shortage of fats, low temperature, vermin predation, carbon dioxide build-up, calcitic migration and many other complications. Some people awake with only enough vestigial memory to walk and eat, and became known as "nightwalkers".

As the novel opens, people’s survivability during hibernation has dramatically increased after the introduction of Morphenox, a drug produced by HiberTech, a large and powerful "vertically integrated" corporation. HiberTech also "takes care" of nightwalkers, "redeploying" those who are suitable for performing simple tasks and supervising "transplant potential" of others.

There is a Winter Consul Service responsible for the safety of dreaming people. The main protagonist, Charlie Worthing, is a novice and this is their first season as Winter Consul. One of the current issues for the Consul Service is an outbreak of viral dreams that is not treated seriously at first, but unexpectedly leads to serious trouble in which Charlie is personally embroiled.

The novel is notable because Fforde never uses a gender descriptive pronoun for the protagonist Charlie Worthing, referring to Charlie variously as they/them, I/me, and as simply 'Charlie'.

Reception

Early Riser was listed 10th in the New York Times Best-Seller Books Hardcover Fiction on 3rd of March, 2019 [3].

"As Charlie uncovers a conspiracy connected with a viral dream, Fforde keeps the puns and neologisms coming thick and fast while exploring every facet of his novel’s intriguing premise." - James Lovegrove, Financial Times (November 30, 2018) [4]

"Early Riser is a zany send-up of all things British and an often hilarious account of Charlie’s stumbling, hare-brained attempts to work out the secret of the authoritarian HiberTech company." - Eric Brown, The Guardian (September 7, 2018) [5]

"Early Riser has all of the elements and sensibility that have earned Fforde a sizable and devoted following: wordplay, allusion, a playful exuberance and -- of course -- his signature method of World-Building via Copious and Suggestive Use of Capitalization, often in the service of creating Imaginary Socioeconomic Hierarchies and Related Governmental Agencies. (...) Fforde writes witty, chewy sentences, full of morsels, and delivers them deadpan. (...) It’s not so much that the book is less than the sum of its parts. It’s just that there are so many parts. Early Riser, while never underwritten, can be at times a bit underfelt, the verbal dexterity crowding out the room for emotion." - Charles Yu, The New York Times Book Review (February 28, 2019) [6]

References

  1. "Jasper Fforde returns with new 'rich, dark' novel | The Bookseller". www.thebookseller.com. Retrieved 2019-04-30.
  2. Alexander, Niall (2018-08-03). "Oh What A Miserable Winter: Early Riser by Jasper Fforde". Tor.com. Retrieved 2019-04-30.
  3. "Books Best Sellers Hardcover Fiction". New York Times. 2019-03-03. Retrieved 2019-04-30.
  4. Lovegrove, James (2018-11-30). "Short review: Early Riser by Jasper Fforde". Financial Times. Retrieved 2019-04-30.
  5. Brown, Eric (2018-09-07). "The best recent science fiction novels – review roundup". The Guardian. Retrieved 2019-04-30.
  6. Yu, Charles (2019-02-28). "A Brilliantly Funny and Slightly Bonkers New Novel From Jasper Fforde". New York Times. Retrieved 2019-04-30.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.